- Home
- CXM vs LGND Comparison
CXM vs LGND Comparison
Compare CXM & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXM
- LGND
- Stock Information
- Founded
- CXM 2009
- LGND 1987
- Country
- CXM United States
- LGND United States
- Employees
- CXM N/A
- LGND N/A
- Industry
- CXM Computer Software: Prepackaged Software
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- CXM Technology
- LGND Health Care
- Exchange
- CXM Nasdaq
- LGND Nasdaq
- Market Cap
- CXM 2.1B
- LGND 2.0B
- IPO Year
- CXM 2021
- LGND 1992
- Fundamental
- Price
- CXM $9.12
- LGND $122.40
- Analyst Decision
- CXM Hold
- LGND Strong Buy
- Analyst Count
- CXM 14
- LGND 8
- Target Price
- CXM $10.00
- LGND $144.71
- AVG Volume (30 Days)
- CXM 3.6M
- LGND 139.7K
- Earning Date
- CXM 09-03-2025
- LGND 08-05-2025
- Dividend Yield
- CXM N/A
- LGND N/A
- EPS Growth
- CXM 90.78
- LGND N/A
- EPS
- CXM 0.40
- LGND N/A
- Revenue
- CXM $805,936,000.00
- LGND $181,488,000.00
- Revenue This Year
- CXM $4.70
- LGND $18.41
- Revenue Next Year
- CXM $4.79
- LGND $18.87
- P/E Ratio
- CXM $22.54
- LGND N/A
- Revenue Growth
- CXM 6.75
- LGND 53.40
- 52 Week Low
- CXM $6.75
- LGND $81.74
- 52 Week High
- CXM $9.99
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- CXM 64.56
- LGND 70.36
- Support Level
- CXM $8.61
- LGND $111.72
- Resistance Level
- CXM $9.02
- LGND $115.53
- Average True Range (ATR)
- CXM 0.31
- LGND 3.46
- MACD
- CXM 0.08
- LGND 0.18
- Stochastic Oscillator
- CXM 95.20
- LGND 85.52
About CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.